Discussion of talks from the symposium: Factor X: From thrombokinase to oral anti-coagulants and beyond

por Milstone, Leonard M., Jackson, Craig, Becker, Richard C., Camire, Rodney, Knabb, Robert, Mann, Kenneth, Ruf, Wolfram, Wexler, Ruth R., Wood, Jeremy
Publicado 2021

Milvexian, an orally bioavailable, small‐molecule, reversible, direct inhibitor of factor XIa: In vitro studies and in vivo evaluation in experimental thrombosis in rabbits

por Wong, Pancras C., Crain, Earl J., Bozarth, Jeffrey M., Wu, Yiming, Dilger, Andrew K., Wexler, Ruth R., Ewing, William R., Gordon, David, Luettgen, Joseph M.
Publicado 2021

Discovery of Highly Potent Liver X Receptor β Agonists

por Kick, Ellen K., Busch, Brett B., Martin, Richard, Stevens, William C., Bollu, Venkataiah, Xie, Yinong, Boren, Brant C., Nyman, Michael C., Nanao, Max H., Nguyen, Lam, Plonowski, Artur, Schulman, Ira G., Yan, Grace, Zhang, Huiping, Hou, Xiaoping, Valente, Meriah N., Narayanan, Rangaraj, Behnia, Kamelia, Rodrigues, A. David, Brock, Barry, Smalley, James, Cantor, Glenn H., Lupisella, John, Sleph, Paul, Grimm, Denise, Ostrowski, Jacek, Wexler, Ruth R., Kirchgessner, Todd, Mohan, Raju
Publicado 2016

Selective FPR2 Agonism Promotes a Proresolution Macrophage Phenotype and Improves Cardiac Structure-Function Post Myocardial Infarction

por García, Ricardo A., Lupisella, John A., Ito, Bruce R., Hsu, Mei-Yin, Fernando, Gayani, Carson, Nancy L., Allocco, John J., Ryan, Carol S., Zhang, Rongan, Wang, Zhaoqing, Heroux, Madeleine, Carrier, Marilyn, St.-Onge, Stéphane, Bouvier, Michel, Dudhgaonkar, Shailesh, Nagar, Jignesh, Bustamante-Pozo, Moises M., Garate-Carrillo, Alejandra, Chen, Jian, Ma, Xiuying, Search, Debra J., Dierks, Elizabeth A., Kick, Ellen K., Wexler, Ruth R., Gordon, David A., Ostrowski, Jacek, Wurtz, Nicholas R., Villarreal, Francisco
Publicado 2021